PharmiWeb5d
Atrial Fibrillation Device Market: Growth, Trends, and Future Outlook
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...
Hometown Source8d
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent atrial fibrillation
Dr. Jay Sengupta, MD, senior cardiologist, AHMHI, and researcher, Minneapolis Heart Institute Foundation (MHIF), successfully ...
Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client
DelveInsight, a leader in pharma consulting services, conducted an Asset Prioritization Analysis for a pharmaceutical client entering the Atrial Fibrillation space. The client sought evidence-based ...
Free AFib education class held Wednesday in Wausau
WAUSAU, Wis. (WSAW) - A free seminar is being held Wednesday evening in Wausau to educate people about AFib. Atrial ...
Prevention and treatment of cardiovascular diseases
Dr. Ron Aviles explains available procedures and recovery time for those with heart and vascular conditions. Sponsored by Overlake Medical Center and Clinics.
Le Lézard2h
Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug ...
buckscountyherald5d
Doylestown Health expands treatment options for patients with atrial fibrillation with ablation system
Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary system that ...